How Do Molecular Tweezers Bind to Proteins? Lessons from X-ray Crystallography.

14-3-3 proteins molecular tweezers protein crystallography supramolecular chemistry Δ1-pyrroline-5-carboxyl-dehydrogenase (P5CDH/ALDH4A1)

Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
12 Apr 2024
Historique:
received: 23 02 2024
revised: 03 04 2024
accepted: 05 04 2024
medline: 27 4 2024
pubmed: 27 4 2024
entrez: 27 4 2024
Statut: epublish

Résumé

To understand the biological relevance and mode of action of artificial protein ligands, crystal structures with their protein targets are essential. Here, we describe and investigate all known crystal structures that contain a so-called "molecular tweezer" or one of its derivatives with an attached natural ligand on the respective target protein. The aromatic ring system of these compounds is able to include lysine and arginine side chains, supported by one or two phosphate groups that are attached to the half-moon-shaped molecule. Due to their marked preference for basic amino acids and the fully reversible binding mode, molecular tweezers are able to counteract pathologic protein aggregation and are currently being developed as disease-modifying therapies against neurodegenerative diseases such as Alzheimer's and Parkinson's disease. We analyzed the corresponding crystal structures with 14-3-3 proteins in complex with mono- and diphosphate tweezers. Furthermore, we solved crystal structures of two different tweezer variants in complex with the enzyme Δ

Identifiants

pubmed: 38675584
pii: molecules29081764
doi: 10.3390/molecules29081764
pii:
doi:

Substances chimiques

Ligands 0
14-3-3 Proteins 0
Proteins 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : SFB 1093, project A3 and Z2

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Auteurs

Arthur T Porfetye (AT)

Department of Mechanistic Cell Biology, Max-Planck Institute of Molecular Physiology, Otto-Hahn-Straße 11, 44227 Dortmund, Germany.

Patricia Stege (P)

Department of Mechanistic Cell Biology, Max-Planck Institute of Molecular Physiology, Otto-Hahn-Straße 11, 44227 Dortmund, Germany.

Rocio Rebollido-Rios (R)

Faculty of Biology, University of Duisburg-Essen, Universitätsstrasse 5, 45141 Essen, Germany.

Daniel Hoffmann (D)

Faculty of Biology, University of Duisburg-Essen, Universitätsstrasse 5, 45141 Essen, Germany.

Thomas Schrader (T)

Faculty of Chemistry, University of Duisburg-Essen, Universitätsstrasse 7, 45117 Essen, Germany.

Ingrid R Vetter (IR)

Department of Mechanistic Cell Biology, Max-Planck Institute of Molecular Physiology, Otto-Hahn-Straße 11, 44227 Dortmund, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH